Eli Lilly and Company (NYSE: LLY) today announced that new results from a number of studies across the company's oncology product and pipeline portfolio will be presented at the 54th Annual...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the first positive Phase 1 clinical data assessing cemiplimab as a potential treatment for advanced non-small cell...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that a wide selection of abstracts highlighting the Company's diverse oncology portfolio...

MEI Pharma, Inc. (NASDAQ: MEIP), a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer, today announced...

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced it will present data about the company's portfolio of investigational oncology medicines during the American...

Robert H. Gregg II, DDS, Founder of Millennium Dental Technologies and inventor of the patented LANAP protocol, will present "Lasers for Periodontal Bone Regeneration" at CDA Presents in Anaheim....

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that...

ViewRay®, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to present at the UBS Global Healthcare Conference in

World Tea Expo, the leading tradeshow focused on advancing the business of tea, will present the World Tea Awards (#TeaAwards) from 6 to 8 p.m. on Tuesday, June 12 at the Las Vegas Convention...

Medallia, Inc. (www.medallia.com), the global leader in customer experience management, today announced the Medallia for Digital Partner Program to bring together the voice of the customer with...